JAZZ earnings: next report 2026-08-03, real EPS beat/miss history, analyst consensus Buy, P/E 610.76. Updated 2026-07-23.
Jazz Pharmaceuticals (JAZZ) Research Hub
Jazz Pharmaceuticals (JAZZ) trades on NASDAQ, IE in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 245.8 USD (+1.86%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 610.76, market cap 15.83B. This hub links to the full technical, earnings and options research available for JAZZ.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, IE |
| Last close | 245.8 USD (+1.86%) |
| 52-week range | 224.27 USD – 266.38 USD |
| Trend regime | Range |
| 14-day RSI | 40.8 (Bearish) |
| Trailing P/E | 610.76 |
| Market cap | 15.83B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-03 |
Available research for JAZZ
Covered Call on JAZZ: how it works, illustrative setup around the real 245.8 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on JAZZ: how it works, illustrative setup around the real 245.8 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on JAZZ: how it works, illustrative setup around the real 245.8 USD price, max profit/loss, breakeven and when to use it. Educational.
JAZZ technical analysis: range, last 245.8 USD, RSI 40.8, 52w range 224.27 USD–266.38 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is JAZZ in?
Jazz Pharmaceuticals (JAZZ) is classified under Healthcare (Biotechnology), listed on NASDAQ, IE.
Is JAZZ in an uptrend or downtrend?
As of 2026-09-11, JAZZ is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is JAZZ's trailing P/E ratio?
JAZZ's trailing P/E is 610.76, with a market cap of 15.83B. See the earnings research page for full valuation detail.
When does JAZZ next report earnings?
JAZZ is next scheduled to report earnings on 2026-08-03, with a consensus EPS estimate of 6.18 USD.